Literature DB >> 4088108

Diabetes and impaired glucose tolerance. A prevalence estimate based on the Busselton 1981 survey.

C Glatthaar, T A Welborn, N S Stenhouse, P Garcia-Webb.   

Abstract

We have estimated the prevalence of diabetes and impaired glucose tolerance from the Busselton 1981 Population Survey using the 1980 World Health Organization (WHO) criteria. Standardized to the Australian non-Aboriginal population aged 25 years and over, the prevalence rates in this white community were 2.5% for known diabetes; 0.9% for newly discovered diabetes; 2.9% for impaired glucose tolerance; and 6.3% for all categories of abnormal glucose tolerance. There appears to have been a real increase in the frequency of diabetes since 1966. Using fasting serum C-peptide values and clinical criteria, 14% of all diabetic subjects were insulin-dependent. The male:female ratio for all categories of abnormal glucose tolerance was 1.4:1. Data from the United States indicate spectacularly higher rates for diabetes and impaired glucose tolerance in the white population. A national study of the prevalence of diabetes and impaired glucose tolerance in Australia is recommended. For epidemiological purposes, a single blood glucose value two hours after a 75 g oral glucose tolerance test is sufficient to categorize glucose tolerance as defined by WHO.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4088108     DOI: 10.5694/j.1326-5377.1985.tb123131.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  9 in total

1.  Type 1 (insulin-dependent) diabetes in Tasmania: prevalence and apparent regional differences.

Authors:  H King; J Dixon; G Senator; M Schooneveldt; P Zimmet
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

Review 2.  Impaired glucose tolerance.

Authors:  J S Yudkin; K G Alberti; D G McLarty; A B Swai
Journal:  BMJ       Date:  1990-09-01

3.  Stroke topography and outcome in relation to hyperglycaemia and diabetes.

Authors:  L Kiers; S M Davis; R Larkins; J Hopper; B Tress; S C Rossiter; J Carlin; S Ratnaike
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

4.  Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II.

Authors:  Wendy A Davis; Kirsten E Peters; Ashley Makepeace; Shaye Griffiths; Christine Bundell; Struan F A Grant; Sian Ellard; Andrew T Hattersley; Stephen A Paul Chubb; David G Bruce; Timothy M E Davis
Journal:  Intern Med J       Date:  2018-07       Impact factor: 2.048

Review 5.  Epidemiology of type II diabetes: an international perspective.

Authors:  T J Songer; P Z Zimmet
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

6.  Diabetes and glucose tolerance in New South Wales coastal Aborigines: possible effects of non-Aboriginal genetic admixture.

Authors:  D R Williams; P S Moffitt; J S Fisher; H V Bashir
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

7.  Islet cell antibodies and other markers of autoimmunity and diabetes mellitus in Nauruans.

Authors:  S Bakos; I R Mackay; M J Rowley; W Knowles; P Zimmet
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

Review 8.  Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis.

Authors:  Yu Tong; Ying Lin; Yuan Zhang; Jiyun Yang; Yawei Zhang; Hengchuan Liu; Ben Zhang
Journal:  BMC Med Genet       Date:  2009-02-19       Impact factor: 2.103

9.  The influence of ethnicity on the development of type 2 diabetes mellitus in women with gestational diabetes: a prospective study and review of the literature.

Authors:  Christian M Girgis; Jenny E Gunton; N Wah Cheung
Journal:  ISRN Endocrinol       Date:  2012-04-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.